Business Wire

NY-SERMO

1.12.2022 15:06:35 CET | Business Wire | Press release

Share
Sermo Survey Finds Opportunity to Educate General Care Physicians on PrEP to Increase Patient Adoption

Timed to World AIDS Day, Sermo, a physician-first online community and leader in global HCP insights, released a new survey that found 46% of general care physicians including PCPs, OB-GYNs, and pediatric physicians, reported they feel they do not have enough knowledge about currently approved PrEP medication options to prescribe them to patients. Whereas 98% of infectious disease specialists reported they felt they have enough knowledge about PrEP medications signaling a need for further education from industry stakeholders for noninfectious disease specialists. An important area of opportunity as patients who are likely good candidates for PrEP often go to a PCP instead of seeking out an infectious disease specialist.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221201005355/en/

The cost of PrEP continues to be a driving factor for patients’ decision to decline treatment in the U.S. as reported by 26% of surveyed physicians. However, PrEP is fully covered in most instances when a patient has private insurance, highlighting another opportunity to further educate patients and providers via patient support and financial assistance programs. Despite PrEP private insurance coverage, young adults 26 years old and under face insurance barriers to accessing PrEP. 23% of surveyed physicians said they don’t know of any resources to help patients on their parent's insurance who want to access PrEP but don’t want their parents to find out. This number declined to 16% when surveying just infectious disease specialists, suggesting an area of opportunity for wider outreach among patient support and financial assistance programs to help this patient population.

Concerns about the cost being the driving factor for patients declining PrEP are lower in Europe than in the U.S. When comparing physician experiences, cost was the number one driver of patients declining PrEP treatment compared to the number three reason in the EU5. The rest of the world followed the U.S. sentiment of cost being the leading reason patients decline PrEP. In Europe, physicians reported the top reason patients declined PrEP treatment is planning to take other preventative measures (27%), followed by stigma (24%), and then cost (20%).

PrEP Adoption Faces Challenges on Multiple Fronts Beyond Cost and Education:

  • PrEP isn’t top-of-mind for most patients: only 16% of surveyed physicians reported that patients often proactively asked them for PrEP.
  • Patients struggle to maintain adherence to PrEP: 70% of surveyed physicians reported that patients often or sometimes have a hard time adhering to the once-a-day pill schedule of taking PrEP.
  • Misinformation about how PrEP works persists as 49% of surveyed physicians reported hearing misinformation about the treatment from patients in their practices.
  • When asked the most common misinformation they hear in their practices, PrEP is only for men who have sex with other men is what they heard most often as reported by 63% of physicians. This is in contradiction with the reality that an average of 22% of new HIV diagnoses each year are from heterosexual contact.

“HIV is 100% preventable. Education for both providers and patients is critical in making more progress against the HIV/AIDS epidemic,” says Dr. Claudia Martorell, an Infectious Disease Specialist and Sermo Medical Advisory Board Member. “Education, along with improved insurance coverage, increased medication awareness, better access for at-risk populations, and decreasing stigma around HIV infection all support our ability to do a better job in ending the epidemic.”

Cost & Adherence Keep HIV Patients From Successful Treatment Regiments:
Similar to concerns about the cost of PrEP, affordability is the key treatment attribute that is most important to physicians when recommending an HIV medication to a patient (17%) followed by fewer side effects (15%), and less medication to take each day (13%). In addition, physicians reported adherence is another key barrier to HIV treatment as more than half (56%) of physicians reported that patients they are treating for HIV/AIDS have a difficult time following a strict medication adherence program. Interest in longer-lasting injectable medications is likely to be high among HIV patients, as 48% of surveyed physicians reported that patients simply forgetting to take their medication is the top reason patients didn’t adhere to treatment plans. Multidrug-resistant HIV is also a huge concern for physicians as nearly half (43%) reported treating patients with these issues.

This survey was fielded as part of Sermo’s ongoing Barometer survey. The survey included more than 600 global physicians who were surveyed between November 2nd - 14th, 2022. To explore more findings, visit app.sermo.com/barometer.

About Sermo:
Sermo turns physician experience, expertise, and observations into actionable insights for the global healthcare community. Engaging with more than 1.3 million HCPs across 150 countries, the company provides physicians with a social platform and unique community that fosters impactful peer-to-peer collaboration & discussions about issues that are important to them and their patients. Sermo offers on-demand access to physicians via a suite of proprietary technology to provide business intelligence that benefits pharmaceutical, healthcare partners, and the medical community at large. To learn more, visit www.sermo.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221201005355/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Picsart Opens the AI Behind Its Platform to Developers & Businesses20.11.2026 20:54:00 CET | Press release

With Picsart Platform, developers can build their own video, audio, image features using 250+ models from 30+ providers, alongside Picsart's own editing models, through one API, CLI or MCP server. Key Takeaways One bundle, four ways to build: the API, the CLI, a playground to test models, and Picsart Media Studio, an MCP server that works with compatible AI assistants. One integration for image, video, audio and text generation from 250+ models across 30+ providers, with the freedom to switch models as a product evolves. Self-serve users pay per generation at competitive, published rates. Developers get access to Picsart's proprietary editing models, like Enhance and background removal, which are only available on Picsart Platform. Picsart, the AI media production and distribution platform backed by Sequoia Capital and SoftBank Vision Fund 2, today launched Picsart Platform - a multimodal creative AI hub that gives developers the technology behind the platform used by more than 100 mil

NetJets Becomes Official Private Aviation Provider of the Hahnenkamm Races in Kitzbühel20.11.2026 18:45:00 CET | Press release

The Partnership brings together two brands committed to excellence, precision and exceptional experiences NetJets, the global leader in private aviation, is delighted to announce its newest partnership with the Hahnenkamm Races in Kitzbühel, Austria, becoming the event's Official Private Aviation Provider. The Hahnenkamm Races are among the most prestigious and celebrated events in world alpine skiing. They attract athletes, business leaders, international guests and winter sports enthusiasts from around the world. Through this partnership, NetJets and the Hahnenkamm Races are aligning two brands renowned for excellence, precision and world-class experiences. The partnership is an exciting addition to NetJets' growing portfolio of premium lifestyle and sporting partnerships, offering Owners unique opportunities to access one of Europe's most iconic winter sporting events. Alongside premium hospitality and unforgettable behind-the-scenes experiences, the collaboration will help create e

Frontgrade Technologies Help Power Critical Computing and Electronics Aboard NASA’s Roman Space Telescope20.11.2026 18:40:00 CET | Press release

Frontgrade processors and radiation-hardened microelectronics support critical spacecraft and instrument functions on NASA’s flagship astrophysics mission Frontgrade today announced that technologies from across its space electronics portfolio are supporting multiple mission-critical systems aboard NASA’s Nancy Grace Roman Space Telescope, which successfully launched on August 30, 2026. Roman is NASA’s flagship astrophysics observatory designed to investigate dark energy, discover exoplanets and explore the evolution of the universe. Its onboard electronics include radiation-hardened processors and microelectronics, providing critical processing, communications, power-management and control functions across the spacecraft. At the centre of Roman’s computing architecture are Frontgrade Gaisler’s GR740 and GR712RC processors. The GR740 radiation-hardened quad-core LEON4FT processor serves as the computing engine for the Wildcat Processor Card, used in the spacecraft’s primary and redunda

Inside Moutai House Singapore: Beyond Baijiu, A Cultural Encounter20.11.2026 16:05:00 CET | Press release

On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120301288/en/ On November 13, Moutai House officially opened at Fullerton Waterboat House in Singapore. As the world’s first Moutai brand experience space built under its new SI standards, this three-storey venue brings together cultural exhibitions, baijiu tasting, distinctive dining and creative cocktails. Using Moutai as a bridge, it creates new opportunities for Chinese baijiu culture to blend with and draw inspiration from Singapore’s diverse lifestyle and cultural scene. As early as 1954, Guizhou Moutai arrived in Singapore via the Singapore River, marking its first entry into Southeast Asia, right across from Fullerton Waterboat House. 72 years later, Moutai House has found its home along the same riverbank, transforming a historic arrival into a lasting presence and turning a con

ViTAA Medical and The Society for Vascular Surgery Announce Strategic Partnership20.11.2026 15:00:00 CET | Press release

ViTAA Medical to Become Key SVS AI Partner, Advancing AI Education and Responsible Adoption in Vascular Care ViTAA Medical Solutions Inc. (ViTAA) today announced a strategic partnership with The Society for Vascular Surgery (SVS) to advance evidence, education, and the responsible adoption of quantitative imaging and artificial intelligence in vascular care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261120954362/en/ The partnership will support evidence building, best practices, educational resources for SVS members, physicians and trainees on AI validation, interpretation, and clinical limitations. The relationship has the potential to pave the way for additional AI tools and resources for SVS members through the Society in the future. The partnership creates a framework for the organizations to lead AI-enabled research opportunities involving imaging and clinical outcomes. Mitchel Benovoy, PhD, Chief Executive Officer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye